As we enter 2026, Tirzepatide continues to be a groundbreaking medication in the field of metabolic health, primarily known under brand names like Mounjaro for type 2 diabetes management and Zepbound for chronic weight management and related conditions. This dual GLP-1 and GIP receptor agonist has transformed treatment options for millions dealing with obesity, diabetes, […]